A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population

Pain

Volumn 157, Issue 1, 2016, Pages 55-64

  Mansfield, Kathryn E ^a   Sim, Julius ^b   Jordan, Joanne L ^b   Jordan, Kelvin P ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

Chronic widespread pain; Fibromyalgia; General population; Meta analysis; Prevalence; Systematic review

Indexed keywords

ADULT; AGE; AMISH; ARTICLE; CHRONIC PAIN; CHRONIC WIDESPREAD PAIN; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; CULTURAL FACTOR; EUROPEAN; FEMALE; HUMAN; MALE; MEDICAL GEOGRAPHY; META ANALYSIS; NORTH AMERICA; OUTCOME ASSESSMENT; POPULATION RESEARCH; POPULATION RISK; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SOUTH ASIAN; SYSTEMATIC REVIEW; TELYCHIAN; AGED; MIDDLE AGED;

ADULT; AGE FACTORS; AGED; CHRONIC PAIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEX FACTORS;

EID: 84953747109     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000314     Document Type: Article

References (43)

1. Ablin JN, Oren A, Cohen S, Aloush V, Buskila D, Elkayam O, Wollman Y, Berman M. Prevalence of fibromyalgia in the Israeli population: a population-based study to estimate the prevalence of fibromyalgia in the Israeli population using the London Fibromyalgia Epidemiology Study Screening Questionnaire (LFESSQ). Clin Exp Rheumatol 2012; 30: 39-43
2. Aggarwal VR, McBeth J, Zakrzewska JM, Lunt M, Macfarlane GJ. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?. Int J Epidemiol 2006; 35: 468-76
3. Assumpção A, Cavalcante AB, Capela CE, Sauer JF, Chalot SD, Pereira CAB, Marques AP. Prevalence of fibromyalgia in a low socioeconomic status population. BMC Musculoskelet Disord 2009; 10: 64
4. Bannwarth B, Blotman F, Roué-Le Lay K, Caubère JP, AndréE, Tä?eb C. Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine 2009; 76: 184-7
5. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-Analysis of prevalence. J Epidemiol Community Health 2013; 67: 974-8
6. Bergman S, Herrstrom PER, Hogstrom K, Petersson IF, Svensson B, Jacobsson LTH, Herrström P, Högström K. Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. J Rheumatol 2001; 28: 1369-77
7. Bergman S, Herrström PER, Lennart TH, Petersson IF, Jacobsson LT. Chronic widespread pain: a three year followup of pain distribution and risk factors. J Rheumatol 2002; 29: 818-25
8. Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caubère JP, Le Lay K, Taieb C, Matucci-Cerinic M. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 2010; 39: 448-53
9. Buskila D, Abramov G, Biton A, Neumann L. The prevalence of pain complaints in a general population in Israel and its implications for utilization of health services. J Rheumatol 2000; 27: 1521-5
10. Carnes D, Parsons S, Ashby D, Breen A, Foster NE, Pincus T, Vogel S, Underwood M. Chronic musculoskeletal pain rarely presents in a single body site: results from a UK population study. Rheumatology (Oxford) 2007; 46: 1168-70
11. Choudhury Y, Bremner SA, Ali A, Eldridge S, Griffiths CJ, Hussain I, Parsons S, Rahman A, Underwood M. Prevalence and impact of chronic widespread pain in the Bangladeshi and white populations of Tower Hamlets, East London. Clin Rheumatol 2013; 32: 1375-82
12. Cimmino MA, Ferrone C, Cutolo M. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol 2011; 25: 173-83
13. Croft P, Rigby AS, Boswell R, Schollum J, Silman A. The prevalence of chronicwidespread pain in the general population. J Rheumatol 1993; 20: 710-13
14. Hardt J, Jacobsen C, Goldberg J, Nickel R, Buchwald D. Prevalence of chronic pain in a representative sample in the United States. Pain Med 2008; 9: 803-12
15. Häuser W, Schmutzer G, Hinz A, Hilbert A, Brähler E. Prävalenz chronischer Schmerzen in Deutschland [in German]. Schmerz 2013; 27: 46-55
16. Hayden JA, van Der Windt DA, Cartwright JL, CôtéP, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med 2013; 158: 280-6
17. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. 2011. Available at: http://handbook. cochrane.org/. Accessed December 3, 2014
18. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-Analyses. BMJ 2003; 327: 557-60
19. Hunt IM, Silman AJ, Benjamin S, McBeth J, Macfarlane GJ. The prevalence and associated features of chronic widespread pain in the community using the "Manchester" definition of chronic widespread pain. Rheumatology (Oxford) 1999; 38: 275-9
20. Jacobsson LTH, NagiDK, PillemerSR, KnowlerWC, Hanson RL, Pettitt DJ, Bennett PH. Low prevalences of chronic widespread pain and shoulder disorders among the Pima Indians. J Rheumatol 1996; 23: 907-9
21. Jordan KP, Kadam UT, Hayward R, Porcheret M, Young C, Croft P. Annual consultation prevalence of regional musculoskeletal problems in primary care: an observational study. BMC Musculoskelet Disord 2010; 11: 144
22. Kim SH, Bae GR, Lim HS. Prevalence and risk factors of fibromyalgia syndrome and chronic widespread pain in two communities in Korea. J Korean Rheum Assoc 2006; 13: 18-25
23. Klemp P, Williams SM, Stansfield SA. Fibromyalgia in Maori and European New Zealanders. J Rheumatol 2002; 41: 554-7
24. Lindell L, Bergman S, Petersson IF, Jacobsson LT, Herrström P. Prevalence of fibromyalgia and chronic widespread pain. Scand J Prim Health Care 2000; 18: 149-53
25. Macfarlane GJ, Palmer B, Roy D, Afzal C, Silman AJ, O'Neill T. An excess of widespread pain among South Asians: are low levels of vitamin D implicated?. Ann Rheum Dis 2005; 64: 1217-9
26. McBeth J, Macfarlane GJ, Benjamin S, Silman AJ. Features of somatization predict the onset of chronic widespread pain: results of a large population-based study. Arthritis Rheum 2001; 44: 940-6
27. McBeth J, Mulvey MR. Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria. Nat Rev Rheumatol 2012; 8: 108-16
28. Mundal I, Gra'we RW, Bjørngaard JH, Linaker OM, Fors EA. Prevalence and long-Term predictors of persistent chronic widespread pain in the general population in an 11-year prospective study: the HUNT study. BMC Musculoskelet Disord 2014; 15: 213
29. Newcombe R. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17: 857-72
30. Nickel R, Raspe HH. Chronischer schmerz: epidemiologie und inanspruchnahme [in German]. Nervenarzt 2001; 72: 897-906
31. Ospina M, Harstall C. Prevalence of Chronic Pain: An Overview. Health Technology Assessment 29. Edmonton, Canada. 2002. Available at: http://www.ihe.ca/documents/prevalence-chronic-pain.pdf. Accessed 25 August 2010
32. Papageorgiou AC, Silman AJ, MacfarlaneGJ. Chronicwidespread pain in the population: a seven year follow up study. Ann Rheum Dis 2002; 61: 1071-4
33. Raspe H, Baumgartner C. The epidemiology of the fibromyalgia syndrome FMS: different criteria-different results. J Musculoskelet Pain 1993; 1: 149-52
34. Reid KJ, Harker J, Bala MM, Truyers C, Kellen E, Bekkering GE, Kleijnen J. Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin 2011; 27: 449-62
35. Scudds RA, Li EKM, Scudds R. The prevalence of fibromyalgia syndrome in Chinese people in Hong Kong. J Musculoskelet Pain 2006; 14: 3-11
36. Shamliyan T, Kane RL, Dickinson S. A systematic review of tools used to assess the quality of observational studies that examine incidence or prevalence and risk factors for diseases. J Clin Epidemiol 2010; 63: 1061-70
37. Storozhenko ON, Lesniak OM, Macfarlane GJ, McBeth J. The prevalence of chronic generalized pain and its relationship to demographic characteristics and mental status. Klin Med (Mosk) 2004; 82: 48-52
38. Verhaak PFM, Kerssens JJ, Dekker J, Sorbi MJ, Bensing JM. Prevalence of chronic benign pain disorder among adults: a review of the literature. PAIN 1998; 77: 231-9
39. White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999; 26: 1570-6
40. White KP, Thompson J. Fibromyalgia syndrome in an Amish community: a controlled study to determine disease and symptom prevalence. J Rheumatol 2003; 30: 1835-40
41. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62: 600-10
42. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19-28
43. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Michael Franklin C, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, Mccain GA, John Reynolds W, Romano TJ, Jon Russell I, Sheon RP. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-72